BUTYLSCOPOLAMINE
General grade
Suitable for diverse pharmaceutical forms
Please be aware that this website is not intended for consumers, as the information provided herein does not refer to finished commercial products that are generally available to the public.
The claims made refer to ingredients only and may not comply with Regulation (EC) No. 1924/2006, the Swiss Federal Act on Foodstuffs and Utility Articles (and related Ordinance), the Swiss Ordinance of the Internal Affairs Department on Information concerning Foodstuffs and Cosmetics, or other relevant regulations in your country. Any claims or statements about the products relating to their health benefits have not been evaluated by the Food and Drug Administration (FDA) and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Any of the ingredients are intended to diagnose, treat, cure, or prevent any disease or health condition.
This website is accessible from various countries around the world. Therefore, it may include statements or information that are not applicable to your country or region.
PLANT
Duboisia
PART OF THE PLANT USED
Leaves
APPEARANCE
White or almost white Crystalline powder
CAS NUMBER
149-64-4
Butylscopolamine is a peripherally-acting antimuscarinic and anticholinergic agent commonly used for its antispasmodic properties
We have been producing our semi-synthetic, pharmaceutical-grade Butylscopolamine since 1985, obtaining it from the leaves of the Duboisia plant sourced from our own cultivation site in Australia
Semi-synthetic powder
Purity grade 98.0%÷101.0%
Suitable for diverse pharmaceutical forms
Suitable for injectable pharmaceutical forms
GACP compliant
Linnea® Australian cultivations of Duboisia
We are proud to be vertically integrated in our supply chain for this important beneficial ingredient. Linnea has been manufacturing Butylscopolamine since 1985 in our GMP certified facility. We manage our own supply chain and have full traceability for this important ingredient.